Statistical Analysis of the Primary Outcome in Acute Stroke Trials

被引:205
作者
Bath, Philip M. W. [2 ]
Lees, Kennedy R. [1 ]
Schellinger, Peter D. [3 ]
Altman, Hernan [4 ]
Bland, Martin [5 ]
Hogg, Cheryl [2 ]
Howard, George [6 ]
Saver, Jeffrey L. [7 ]
机构
[1] Univ Glasgow, Western Infirm, Glasgow G11 6NT, Lanark, Scotland
[2] Univ Nottingham, Nottingham NG7 2RD, England
[3] JW Klinikum Minden, Minden, Germany
[4] Brainsgate, Caesarea, Israel
[5] Univ York, York YO10 5DD, N Yorkshire, England
[6] Univ Alabama Birmingham, Birmingham, AL USA
[7] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA
关键词
acute Rx; outcomes; randomized controlled trials; RANDOMIZED CONTROLLED-TRIALS; ACUTE ISCHEMIC-STROKE; TISSUE-PLASMINOGEN ACTIVATOR; SAMPLE-SIZE CALCULATIONS; TRAUMATIC BRAIN-INJURY; POST HOC ANALYSIS; ENTIRE RANGE; THROMBOLYTIC THERAPY; CLINICAL-TRIALS; END-POINTS;
D O I
10.1161/STROKEAHA.111.641456
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Common outcome scales in acute stroke trials are ordered categorical or pseudocontinuous in structure but most have been analyzed as binary measures. The use of fixed dichotomous analysis of ordered categorical outcomes after stroke (such as the modified Rankin Scale) is rarely the most statistically efficient approach and usually requires a larger sample size to demonstrate efficacy than other approaches. Preferred statistical approaches include sliding dichotomous, ordinal, or continuous analyses. Because there is no best approach that will work for all acute stroke trials, it is vital that studies are designed with a full understanding of the type of patients to be enrolled (in particular their case mix, which will be critically dependent on their age and severity), the potential mechanism by which the intervention works (ie, will it tend to move all patients somewhat, or some patients a lot, and is a common hazard present), a realistic assessment of the likely effect size, and therefore the necessary sample size, and an understanding of what the intervention will cost if implemented in clinical practice. If these approaches are followed, then the risk of missing useful treatment effects for acute stroke will diminish. (Stroke. 2012; 43: 1171-1178.)
引用
收藏
页码:1171 / 1178
页数:8
相关论文
共 60 条
  • [1] Emergency administration of abciximab for treatment of patients with acute ischemic stroke:: Results of an international phase III trial -: Abciximab in emergency treatment of stroke trial (AbESTT-II)
    Adams, Harold P., Jr.
    Effron, Mark B.
    Torner, James
    Davalos, Antoni
    Frayne, Judith
    Teal, Philip
    Leclerc, Jacques
    Oemar, Barry
    Padgett, Lakshmi
    Barnathan, Elliot S.
    Hacke, Werner
    [J]. STROKE, 2008, 39 (01) : 87 - 99
  • [2] Measuring outcomes as a function of baseline severity of ischemic stroke
    Adams, HP
    Leclerc, JR
    Bluhmki, E
    Clarke, W
    Hansen, MD
    Hacke, W
    [J]. CEREBROVASCULAR DISEASES, 2004, 18 (02) : 124 - 129
  • [3] [Anonymous], 1993, An introduction to the bootstrap
  • [4] Should Stroke Trials Adjust Functional Outcome for Baseline Prognostic Factors?
    Bath, Philip
    Gray, Laura J.
    Collier, Timothy
    [J]. STROKE, 2009, 40 (03) : 888 - 894
  • [5] Use of ordinal outcomes in vascular prevention trials - Comparison with binary outcomes in published trials
    Bath, Philip M. W.
    Geeganage, Chamila
    Gray, Laura J.
    Collier, Timothy
    Pocock, Stuart
    [J]. STROKE, 2008, 39 (10) : 2817 - 2823
  • [6] Can we improve the statistical analysis of stroke trials? Statistical reanalysis of functional outcomes in stroke trials
    Bath, Philip M. W.
    [J]. STROKE, 2007, 38 (06) : 1911 - 1915
  • [7] Calculation of numbers-needed-to-treat in parallel group trials assessing ordinal outcomes: case examples from acute stroke and stroke prevention
    Bath, Philip M. W.
    Hogg, Cheryl
    Tracy, Michael
    Pocock, Stuart
    [J]. INTERNATIONAL JOURNAL OF STROKE, 2011, 6 (06) : 472 - 479
  • [8] How a sequential design would have affected the GAIN international study of Gavestinel in stroke
    Bolland, K
    Weeks, A
    Whitehead, J
    Lees, KR
    [J]. CEREBROVASCULAR DISEASES, 2004, 17 (2-3) : 111 - 117
  • [9] Clarke J, 2005, LANCET, V365, P764, DOI 10.1016/S0140-6736(05)17983-5
  • [10] Treatment of acute ischemic stroke with piracetam
    DeDeyn, PP
    DeReuck, J
    Deberdt, W
    Vlietinck, R
    Orgogozo, JM
    [J]. STROKE, 1997, 28 (12) : 2347 - 2352